Cristina Martínez Bueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cristina Martínez Bueno has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Gemma Falguera-Puig
Primary Care Group, Germans Trias i Pujol Research Institute (IGTP), Research Group Atenció a la Salut Sexual i Reproductiva (GRASSIR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Institut Català de la Salut, Barcelona, Spain
3 shared publications - Maria-Mercedes Vicente-Hernández
Institut Català de La Salut, Badalona, Spain
3 shared publications - Rosa Maria Cabedo-Ferreiro
Atenció a la Salut Sexual I Reproductiva (ASSIR) Granollers, Institut Català de la Salut (ICS), Barcelona, Spain; Research Group on Sexual and Reproductive Healthcare (GRASSIR) (2021-SGR-793), Barcelona, Spain
2 shared publications - Aleida Ribas‐Tristany
Atencio a la Salut Sexual i Reproductiva (ASSIR) Sant Adrià, Institut Català de la Salut Sant Adrià de Besòs Spain
1 shared publication - Aneta Monika Zientalska
Obstetrics Department Hospital Universitari Germans Trias i Pujol Badalona Spain
1 shared publication - Anna Berenguera
Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Perceived quality of care of medical abortions in the public health system in Catalonia (Spain)
In Spain, induced abortions are covered by the public health system. In the region of Catalonia, under the scope of Primary Care, the Sexual and Reproducti
- 6 May 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open AccessPerceived quality of care of medical abortions in the public health system in Catalonia (Spain)
In Spain, induced abortions are covered by the public health system. In the region of Catalonia, under the scope of Primary Care, the Sexual and Reproducti
- Open Access
- 9 January 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (5) , 1037-1045
Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study)
Objective: To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. Design: Prospective multicentre observational cohort study. Setting: Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample: Pregnant women attending first‐trimester antenatal visits between October 2022 and September 2024. Methods: All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow‐up. Main Outcome Measures: CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age. Results: Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%–79.1%), and 743 women (22.1%, 95% CI 20.7%–23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%–0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates. Conclusions: Universal first‐trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow‐up.
- 9 January 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (5) , 1037-1045
Open AccessUniversal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study)
Objective: To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. Design: Prospective multicentre observational cohort study. Setting: Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample: Pregnant women attending first‐trimester antenatal visits between October 2022 and September 2024. Methods: All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow‐up. Main Outcome Measures: CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age. Results: Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%–79.1%), and 743 women (22.1%, 95% CI 20.7%–23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%–0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates. Conclusions: Universal first‐trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow‐up.
- Open Access
- 1 March 2023
- Vol. 97
Características de las mujeres migradas atendidas por los Servicios de Salud Reproductiva del Institut Català de la Salut
La feminización de la migración y la necesidad de dar asistencia sanitaria a una población cada vez más diversa, buscando unos datos óptimos de salud, llevó a plantearse esta investigación. El objetivo fue determinar las características (perfil socio-demográfico, antecedentes obstétricos-ginecológicos y el seguimiento) de gestantes migradas con un proceso de embarazo finalizado en 2019 en Cataluña frente a las autóctonas, en centros públicos (ASSIR-ICS). Este estudio descriptivo se basó en los registros de historia clínica informatizada de mujeres en veintiocho centros dependientes del ICS. Se analizaron las variables según la procedencia de las gestantes y se utilizó la prueba de Ji Cuadrado de Pearson al 5% acompañada del residuo estandarizado corregido para compararlas, así como el análisis de la varianza para la comparación de medias también al 5%. Se analizaron 36.315 registros con edad media de 31,1 años. El IMC al inicio de gestación fue de 25,4. El consumo de tabaco fue del 18,1% entre españolas y del 17,3% en el resto de las europeas. El cribado de violencia machista llegó al 4% en latinoamericanas, siendo estadísticamente superior al resto. El riesgo de preeclampsia fue del 23,4% en subsaharianas. La diabetes gestacional fue diagnosticada principalmente entre paquistaníes (18,5%). La prevalencia de Infecciones de Transmisión Sexual (ITS) fue del 8,6% en latinoamericanas, del 5,8% en españolas y del 4,5% en europeas. Las subsaharianas (58,2%) realizaron un control insuficiente de ecografías y un menor porcentaje de visitas con un 49,5%. El seguimiento del embarazo fue insuficiente en el 79,9% del total de las gestantes rurales. Existen diferencias derivadas del origen geográfico de las gestantes que condicionan el acceso a los servicios sanitarios.
- 1 March 2023
- Vol. 97
Open AccessCaracterísticas de las mujeres migradas atendidas por los Servicios de Salud Reproductiva del Institut Català de la Salut
La feminización de la migración y la necesidad de dar asistencia sanitaria a una población cada vez más diversa, buscando unos datos óptimos de salud, llevó a plantearse esta investigación. El objetivo fue determinar las características (perfil socio-demográfico, antecedentes obstétricos-ginecológicos y el seguimiento) de gestantes migradas con un proceso de embarazo finalizado en 2019 en Cataluña frente a las autóctonas, en centros públicos (ASSIR-ICS). Este estudio descriptivo se basó en los registros de historia clínica informatizada de mujeres en veintiocho centros dependientes del ICS. Se analizaron las variables según la procedencia de las gestantes y se utilizó la prueba de Ji Cuadrado de Pearson al 5% acompañada del residuo estandarizado corregido para compararlas, así como el análisis de la varianza para la comparación de medias también al 5%. Se analizaron 36.315 registros con edad media de 31,1 años. El IMC al inicio de gestación fue de 25,4. El consumo de tabaco fue del 18,1% entre españolas y del 17,3% en el resto de las europeas. El cribado de violencia machista llegó al 4% en latinoamericanas, siendo estadísticamente superior al resto. El riesgo de preeclampsia fue del 23,4% en subsaharianas. La diabetes gestacional fue diagnosticada principalmente entre paquistaníes (18,5%). La prevalencia de Infecciones de Transmisión Sexual (ITS) fue del 8,6% en latinoamericanas, del 5,8% en españolas y del 4,5% en europeas. Las subsaharianas (58,2%) realizaron un control insuficiente de ecografías y un menor porcentaje de visitas con un 49,5%. El seguimiento del embarazo fue insuficiente en el 79,9% del total de las gestantes rurales. Existen diferencias derivadas del origen geográfico de las gestantes que condicionan el acceso a los servicios sanitarios.
- Open Access
- 1 April 2022
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 14, 529-544
Self-Reported Menstrual Alterations During the COVID-19 Syndemic in Spain: A Cross-Sectional Study
Introduction: Available evidence suggests that there might be an association between the stressors experienced during the COVID-19 syndemic and changes in menstrual patterns. The aim of this study was to assess self-reported menstrual alterations during the COVID-19 syndemic among women and people who menstruate aged 18– 55 in Spain. Materials and Methods: A cross-sectional online survey-based study was conducted (March–July 2021). Descriptive statistics were calculated and multivariate logistic regression models were constructed. This study was conducted as part of the “Equity and Menstrual Health in Spain” research project. Results: Among participants (N=17,455), 39.4% reported menstrual alterations since the start of the syndemic. Participants self-reporting long COVID-19 presented higher odds of menstrual alterations (aOR: 1.34, 95% CI, 1.15-1.57). In participants with no history of COVID-19, the risk for self-reported menstrual alterations was significantly higher based on employment situation, among participants experiencing financial issues (eg, financial issues always/many times < 12 months: aOR: 1.68, 95% CI, 1.48– 1.90), poorer self-perceived health (eg, poor: aOR: 2.00, 95% CI, 1.31– 3.07), and those diagnosed with polycystic ovary syndrome (aOR: 1.13, 95% CI, 1.02– 1.26). Among participants with a self-reported COVID-19 diagnosis, factors that significantly increased the odds for menstrual alterations were experiencing financial strains (eg, financial issues always/many times < 12 months: aOR: 1.53, 95% CI, 1.09– 2.14), poorer self-perceived health (eg, poor: aOR: 3.09, 95% CI, 1.01– 9.52). Overall, factors that decreased the odds of reporting menstrual alterations included age > 25, being a carer, not having a gynecological condition and using hormonal contraception. Discussion and conclusions: Findings suggest an impact of the COVID-19 syndemic on menstrual patterns. Social inequities in reporting menstrual alterations were identified. While the risk of reporting menstrual alterations was higher among participants with long COVID-19, evidence is not conclusive. Further research on menstrual health in the context of COVID-19 is needed, also to inform policy and practice.
- 1 April 2022
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 14, 529-544
Open AccessSelf-Reported Menstrual Alterations During the COVID-19 Syndemic in Spain: A Cross-Sectional Study
Introduction: Available evidence suggests that there might be an association between the stressors experienced during the COVID-19 syndemic and changes in menstrual patterns. The aim of this study was to assess self-reported menstrual alterations during the COVID-19 syndemic among women and people who menstruate aged 18– 55 in Spain. Materials and Methods: A cross-sectional online survey-based study was conducted (March–July 2021). Descriptive statistics were calculated and multivariate logistic regression models were constructed. This study was conducted as part of the “Equity and Menstrual Health in Spain” research project. Results: Among participants (N=17,455), 39.4% reported menstrual alterations since the start of the syndemic. Participants self-reporting long COVID-19 presented higher odds of menstrual alterations (aOR: 1.34, 95% CI, 1.15-1.57). In participants with no history of COVID-19, the risk for self-reported menstrual alterations was significantly higher based on employment situation, among participants experiencing financial issues (eg, financial issues always/many times < 12 months: aOR: 1.68, 95% CI, 1.48– 1.90), poorer self-perceived health (eg, poor: aOR: 2.00, 95% CI, 1.31– 3.07), and those diagnosed with polycystic ovary syndrome (aOR: 1.13, 95% CI, 1.02– 1.26). Among participants with a self-reported COVID-19 diagnosis, factors that significantly increased the odds for menstrual alterations were experiencing financial strains (eg, financial issues always/many times < 12 months: aOR: 1.53, 95% CI, 1.09– 2.14), poorer self-perceived health (eg, poor: aOR: 3.09, 95% CI, 1.01– 9.52). Overall, factors that decreased the odds of reporting menstrual alterations included age > 25, being a carer, not having a gynecological condition and using hormonal contraception. Discussion and conclusions: Findings suggest an impact of the COVID-19 syndemic on menstrual patterns. Social inequities in reporting menstrual alterations were identified. While the risk of reporting menstrual alterations was higher among participants with long COVID-19, evidence is not conclusive. Further research on menstrual health in the context of COVID-19 is needed, also to inform policy and practice.